The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 322.00
Ask: 324.00
Change: 2.00 (0.63%)
Spread: 2.00 (0.621%)
Open: 324.00
High: 324.00
Low: 319.00
Prev. Close: 320.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - BANK OF CYPRUS HOLDINGS PLC

23 Sep 2022 13:44

RNS Number : 4993A
Barclays PLC
23 September 2022
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

BANK OF CYPRUS HOLDINGS PLC

Class of relevant security to which the

€0.10 ordinary shares

dealings being disclosed relate (Note 2)

Date of dealing

22 September 2022

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security

 

dealt in (Note 3)

 

Class of relevant security:

€0.10 ordinary shares

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

16,745,345

3.75%

0

0.00%

(2)

Derivatives (other than options):

0

0.00%

16,742,732

3.75%

(3)

Options and agreements to

purchase/sell:

0

0.00%

0

0.00%

TOTAL:

16,745,345

3.75%

16,742,732

3.75%

(b)

Interests and short positions in relevant securities of the company,

 

other than the class dealt in

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

(2)

Derivatives (other than options):

(3)

Options and agreements to

purchase/sell:

TOTAL:

3.

DEALINGS (Note 4)

(a)

Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1,183

1.2200 GBP

Purchase

8,526

1.2167 GBP

Sale

9,709

1.2171 GBP

(b)

Derivatives transactions (other than options)

 

Product Name

Nature of transaction

Number of relevant securities

Price per unit

(c)

Options transactions in respect of existing securities

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

 

Product name

Number of

Exercise price per

securities

unit

(d)

Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

Details

Price per unit (if

applicable)

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

23 Sep 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISELJMTTMTITBBT
Date   Source Headline
26th Apr 20241:21 pmRNSDate of announcement of 1Q2024 FR
26th Apr 20247:03 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:26 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:00 amRNSIssue of Green Senior Preferred Notes by BOC PCL
24th Apr 20247:00 amRNSBOCH - Transaction in Own Shares
24th Apr 20247:00 amRNSTR1 Notification - Helikon
24th Apr 20247:00 amRNSTR1 Notification -Helikon
23rd Apr 20247:25 amRNSBOCH - Transactions in Own Shares
22nd Apr 20247:27 amRNSBOCH - Transactions in Own Shares
19th Apr 20247:41 amRNSLaunch of share buyback programme
12th Apr 202410:02 amRNSNotice of AGM
5th Apr 20247:20 amRNS2023 Pillar 3 Disclosures
2nd Apr 20241:21 pmRNSTR1 Notification of Holdings - OSOME
2nd Apr 202412:59 pmRNSTR1 Notification of Holdings - OSOME
28th Mar 20242:24 pmRNSBOC Annual Financial Report 2023 Announcement
28th Mar 20241:31 pmRNSBOCH Annual Financial Report 2023 Announcement
28th Mar 20241:30 pmRNSFY2023 Investor Presentation Announcement
28th Mar 20241:30 pmRNSFY2023 Group Financial Results
20th Mar 20247:00 amRNSAnnouncement of Distribution
15th Mar 20249:21 amRNSDate of Announcement of Audited FY2023 FS
19th Feb 20247:01 amRNSDoc re. (Prelim FY2023 Investor Presentation)
19th Feb 20247:00 amRNSPreliminary FY2023 Group Financial Results
6th Feb 20248:41 amRNSDate of announcement of Preliminary FY2023 FR
22nd Dec 20239:09 amRNSRevised Date of AGM
20th Dec 20238:32 amRNSChanges in the composition of the BOD & Committees
13th Dec 20237:00 amRNSEU-wide Transparency Exercise 2023
11th Dec 20232:51 pmRNSChanges in the composition of the BOD
29th Nov 202310:28 amRNSDecision to call AT1 Capital Securities
29th Nov 20238:19 amRNSDate of Annual General Meeting
20th Nov 20239:58 amRNSAppointment of New Director
13th Nov 20237:00 amRNSDoc re. (9M2023 Investor Presentation)
13th Nov 20237:00 amRNS9M2023 Group Financial Results
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer
19th Jun 202312:34 pmRNSTR1 Notification of Major Holdings - Caius
13th Jun 20233:43 pmRNSRefinancing of AT1 Capital Securities
12th Jun 202311:36 amRNSPDMR Notification of Transaction – Iordanou
12th Jun 20239:40 amRNSLaunch of Cash Tender Offer for AT1 Cap.Securities
12th Jun 20238:39 amRNSPDMR Notification of Transaction – Iordanou
8th Jun 20239:01 amRNSDoc re. (Investor Presentation Update)
8th Jun 20239:00 amRNSAnnouncement for the Investor Update Event

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.